PDL BioPharma Story Overview

PDLI -- USA Stock  

USD 2.56  0.03  1.16%

Macroaxis does not monitor all media channels or aggregates social signals for PDL BioPharma. But even though we do not provide professional-grade financial sentiment analysis on PDL BioPharma, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for PDL BioPharma. Additionally take a look at PDL BioPharma Hype Analysis, PDL BioPharma Correlation and PDL BioPharma Performance.
Taking Tally Of The New York Times Company , PDL BioPharma, Inc.
The shares of The New York Times Company have increased by more than 33.46 percent this year alone. The shares recently went down by -4.83 percent or -0.9 and now trades at 17.75. The Dirty Secret to Trading PDL BioPharma, Inc. , The New York Times ... - USA Commerce Daily

Read More...   

Story Momentum

This media report from stocknewsgazette.com distributed on December 8, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 1.75% . The trading delta at closing time when the story was published against the current closing price is 10.53% .

Similar stores for PDL BioPharma

Notable Stocks to Keep Your Eyes on Cypress Semiconductor Corporation, , PDL BioPharma, Inc ...news
Global Export Lines Time to Get Greedy With Cypress Semiconductor Stock Motley FoolFull coverage
few days ago at http://hillaryhq.com 
Dillon Associates Has Raised By 559680 Its Facebook Holding PDL Biopharma Has 0.78 Sentiment
news
Hillary HQ Average True Range under Review PDL BioPharma, Inc. , GAIN Capital Holdings, Inc ... Stocks News Point PDL BioPharma, Inc. Analysts See 0.06 EPS ALTURA MINING LTD ORDINARY SHARES AUSTR Full coverage
over a week ago at http://www.stocksnewspoint.com 
Return on Equity Evaluation PDL BioPharma, Inc. , China Rapid Finance Limited NYSEXRF ...
news
Stocks News Point PDL Biopharma Inc Institutional Investors Sentiment Index Crashed in Q1 2018 Florida Recorder PDL Biopharma Inc Shifting Institutional Investors Sentiment SC Daily Full coverage
over two weeks ago at www.macroaxis.com 
Sale by Mcdade Mark of 10000 shares of PDL BioPharma
Macroaxis News
Filed transaction by Pdl Biopharma Inc director. General open market or private sale of non-derivative or derivative security
over two weeks ago at http://globalexportlines.com 
Wobbling Stocks PDL BioPharma, Inc., , General Dynamics Corporation,
news
Global Export Lines Are These Stocks A Sure Bet PDL BioPharma, Inc. , The Trade Desk, Inc. StockNewsGazetteConfounding Stocks Macys, Inc. , PDL BioPharma, Inc. , Aflac Incorporated The Stock Street Full coverage
over three weeks ago at http://stockspen.com 
Active Mover PDL BioPharma Inc
news
Stocks PenFull coverage
over three weeks ago at http://productioninvestments.com 
Extremely Informative stocks Nutanix, Inc. , PDL BioPharma, Inc.
news
Production Investments Full coverage
over a month ago at http://www.thestocksnews.com 
Take a look at Price Fluctuations PDL BioPharma, Inc.
news
The Stocks News Full coverage
over a month ago at www.macroaxis.com 
Acquisition by Yanai Shlomo of 54348 shares of PDL BioPharma subject to Rule 16b-3
Macroaxis News
Filed transaction by Pdl Biopharma Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at http://stocksmarketcap.com 
Most Recent Figure Make This Stock Even More Attractive PDL BioPharma Inc
news
Stocks Market CapFull coverage
over a month ago at http://www.thestocksnews.com 
Where PDL BioPharma, Inc. stock is Headed Exactly
news
The Stocks News Full coverage
over three months ago at http://stocksmarketcap.com 
Eye-Catching Hot Stock PDL BioPharma Inc
news
Stocks Market CapGreen stock of the month PDL BioPharma, Inc. stock performed 17.97 The Stocks News Mind-blowing Stocks PDL BioPharma, Inc., NASDAQ PDLI, Apple Hospitality REIT, Inc., DailyNyseNews Full coverage
over three months ago at http://www.wallstreetinvestorplace.com 
One Stock for Low Risk Investors PDL BioPharma, Inc.
news
Wallstreet InvestorplaceSEC FORM 4 - SEC.gov SEC.govCisco Systems, Inc. Zacks.comFull coverage

Current Valuation

Current Valuation Comparative Analysis
  Current Valuation 
      PDL BioPharma Comparables 
PDL BioPharma is currently under evaluation in current valuation category among related companies. Enterprise Value is a firm valuation proxy that approximates current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Peers

PDL BioPharma Related Equities
DVAX  6.14 %   
0%
100.0%
DOVA  4.97 %   
0%
80.0%
DRNA  4.70 %   
0%
76.0%
ECYT  2.61 %   
0%
42.0%
CO  0.88 %   
0%
14.0%
EARS  0.04 %   
1.0%
0%
DNLI  0.36 %   
5.0%
0%
NK  0.96 %   
15.0%
0%
EDGE  1.9 %   
31.0%
0%
DMPI  5.05 %   
82.0%
0%
Additionally take a look at PDL BioPharma Hype Analysis, PDL BioPharma Correlation and PDL BioPharma Performance. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.